Titre : Kinésine

Kinésine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Multifactorial Inheritance
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Kinésine : Questions médicales les plus fréquentes", "headline": "Kinésine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Kinésine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-25", "dateModified": "2025-04-20", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Kinésine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Protéines associées aux microtubules", "url": "https://questionsmedicales.fr/mesh/D008869", "about": { "@type": "MedicalCondition", "name": "Protéines associées aux microtubules", "code": { "@type": "MedicalCode", "code": "D008869", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.631.560" } } }, "about": { "@type": "MedicalCondition", "name": "Kinésine", "alternateName": "Kinesins", "code": { "@type": "MedicalCode", "code": "D016547", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ping Xie", "url": "https://questionsmedicales.fr/author/Ping%20Xie", "affiliation": { "@type": "Organization", "name": "Institute of Physics, Chinese Academy of Sciences, Beijing 100190, China. pxie@aphy.iphy.ac.cn." } }, { "@type": "Person", "name": "Kristen J Verhey", "url": "https://questionsmedicales.fr/author/Kristen%20J%20Verhey", "affiliation": { "@type": "Organization", "name": "Department of Biophysics, University of Michigan, Ann Arbor, Michigan; Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan." } }, { "@type": "Person", "name": "Zhenyu Tan", "url": "https://questionsmedicales.fr/author/Zhenyu%20Tan", "affiliation": { "@type": "Organization", "name": "Department of Biophysics, University of Michigan, Ann Arbor, MI, USA." } }, { "@type": "Person", "name": "Alexey I Nesvizhskii", "url": "https://questionsmedicales.fr/author/Alexey%20I%20Nesvizhskii", "affiliation": { "@type": "Organization", "name": "Department of Pathology, University of Michigan, Ann Arbor, MI, USA." } }, { "@type": "Person", "name": "Michael A Cianfrocco", "url": "https://questionsmedicales.fr/author/Michael%20A%20Cianfrocco", "affiliation": { "@type": "Organization", "name": "Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Combination of transcriptome and Mendelian inheritance reveals novel prognostic biomarker of CTLA-4-related lncRNAs and protective role of nitrogen metabolism pathway in lung adenocarcinoma development.", "datePublished": "2024-08-14", "url": "https://questionsmedicales.fr/article/39143529", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-024-12777-7" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.", "datePublished": "2022-11-03", "url": "https://questionsmedicales.fr/article/36348972", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/dad2.12367" } }, { "@type": "ScholarlyArticle", "name": "Exploring the mutational landscape of genes associated with inherited retinal disease using large genomic datasets: identifying loss of function intolerance and outlying propensities for missense changes.", "datePublished": "2022-08-25", "url": "https://questionsmedicales.fr/article/36161854", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjophth-2022-001079" } }, { "@type": "ScholarlyArticle", "name": "Corrigendum: Case Report: Four cases of cardiac sarcoidosis in patients with inherited cardiomyopathy-a phenotypic overlap, co-existence of two rare cardiomyopathies or a second-hit disease.", "datePublished": "2024-02-14", "url": "https://questionsmedicales.fr/article/38420265", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fcvm.2024.1372782" } }, { "@type": "ScholarlyArticle", "name": "Generation of an induced pluripotent stem cell line (LVPEIi002-A) with heterozygous RB1 mutation using peri-orbital fat derived mesenchymal cells of a patient with inherited retinoblastoma.", "datePublished": "2024-02-06", "url": "https://questionsmedicales.fr/article/38335663", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.scr.2024.103329" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Protéines de tissu nerveux", "item": "https://questionsmedicales.fr/mesh/D009419" }, { "@type": "ListItem", "position": 5, "name": "Protéines associées aux microtubules", "item": "https://questionsmedicales.fr/mesh/D008869" }, { "@type": "ListItem", "position": 6, "name": "Kinésine", "item": "https://questionsmedicales.fr/mesh/D016547" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Kinésine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Kinésine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Kinésine", "description": "Comment diagnostiquer une dysfonction des kinésines ?\nQuels examens sont utilisés pour évaluer les kinésines ?\nLes tests sanguins peuvent-ils détecter des anomalies kinésines ?\nQuels symptômes indiquent un problème avec les kinésines ?\nLes biopsies musculaires sont-elles utiles pour les kinésines ?", "url": "https://questionsmedicales.fr/mesh/D016547?mesh_terms=Multifactorial+Inheritance&page=203#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Kinésine", "description": "Quels sont les symptômes d'une déficience en kinésines ?\nLes douleurs musculaires sont-elles liées aux kinésines ?\nComment les kinésines affectent-elles le système nerveux ?\nLes troubles de la vision peuvent-ils être liés aux kinésines ?\nY a-t-il des symptômes cognitifs associés aux kinésines ?", "url": "https://questionsmedicales.fr/mesh/D016547?mesh_terms=Multifactorial+Inheritance&page=203#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Kinésine", "description": "Peut-on prévenir les troubles liés aux kinésines ?\nL'exercice régulier aide-t-il à la santé des kinésines ?\nLes examens médicaux réguliers sont-ils importants ?\nY a-t-il des vaccins pour prévenir les troubles kinésines ?\nLe stress peut-il affecter les kinésines ?", "url": "https://questionsmedicales.fr/mesh/D016547?mesh_terms=Multifactorial+Inheritance&page=203#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Kinésine", "description": "Quels traitements existent pour les troubles kinésines ?\nLa physiothérapie aide-t-elle en cas de dysfonction kinésines ?\nDes suppléments nutritionnels peuvent-ils aider ?\nLes médicaments anti-inflammatoires sont-ils utiles ?\nLa recherche sur les kinésines progresse-t-elle ?", "url": "https://questionsmedicales.fr/mesh/D016547?mesh_terms=Multifactorial+Inheritance&page=203#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Kinésine", "description": "Quelles complications peuvent survenir avec des troubles kinésines ?\nLes troubles kinésines peuvent-ils entraîner des maladies graves ?\nY a-t-il des risques de paralysie avec des troubles kinésines ?\nLes troubles kinésines peuvent-ils affecter la respiration ?\nDes troubles kinésines peuvent-ils causer des problèmes cardiaques ?", "url": "https://questionsmedicales.fr/mesh/D016547?mesh_terms=Multifactorial+Inheritance&page=203#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Kinésine", "description": "Quels sont les facteurs de risque pour les troubles kinésines ?\nLe mode de vie influence-t-il les troubles kinésines ?\nLes antécédents familiaux jouent-ils un rôle ?\nLe stress est-il un facteur de risque pour les kinésines ?\nL'exposition à des toxines influence-t-elle les kinésines ?", "url": "https://questionsmedicales.fr/mesh/D016547?mesh_terms=Multifactorial+Inheritance&page=203#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des kinésines ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests génétiques et des analyses de protéines peuvent aider à diagnostiquer." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer les kinésines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'électrophorèse des protéines et la microscopie électronique sont couramment utilisés." } }, { "@type": "Question", "name": "Les tests sanguins peuvent-ils détecter des anomalies kinésines ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sanguins peuvent révéler des niveaux anormaux de protéines motrices." } }, { "@type": "Question", "name": "Quels symptômes indiquent un problème avec les kinésines ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles neurologiques ou musculaires peuvent signaler une dysfonction des kinésines." } }, { "@type": "Question", "name": "Les biopsies musculaires sont-elles utiles pour les kinésines ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent montrer des anomalies dans les protéines motrices au niveau cellulaire." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en kinésines ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Faiblesse musculaire, troubles de la coordination et problèmes neurologiques." } }, { "@type": "Question", "name": "Les douleurs musculaires sont-elles liées aux kinésines ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs peuvent survenir en raison d'une mauvaise fonction des kinésines." } }, { "@type": "Question", "name": "Comment les kinésines affectent-elles le système nerveux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont essentielles pour le transport des neurotransmetteurs et la signalisation." } }, { "@type": "Question", "name": "Les troubles de la vision peuvent-ils être liés aux kinésines ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies kinésines peuvent affecter les cellules nerveuses de la rétine." } }, { "@type": "Question", "name": "Y a-t-il des symptômes cognitifs associés aux kinésines ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles cognitifs peuvent survenir en raison de dysfonctionnements neuronaux." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés aux kinésines ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée et un mode de vie sain peuvent aider à prévenir certains troubles." } }, { "@type": "Question", "name": "L'exercice régulier aide-t-il à la santé des kinésines ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier favorise la santé musculaire et neuronale." } }, { "@type": "Question", "name": "Les examens médicaux réguliers sont-ils importants ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils permettent de détecter précocement des anomalies kinésines." } }, { "@type": "Question", "name": "Y a-t-il des vaccins pour prévenir les troubles kinésines ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccins spécifiques pour les troubles kinésines." } }, { "@type": "Question", "name": "Le stress peut-il affecter les kinésines ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut nuire à la fonction cellulaire et aux kinésines." } }, { "@type": "Question", "name": "Quels traitements existent pour les troubles kinésines ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique et les médicaments ciblés sont des options de traitement." } }, { "@type": "Question", "name": "La physiothérapie aide-t-elle en cas de dysfonction kinésines ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la physiothérapie peut améliorer la force et la coordination musculaire." } }, { "@type": "Question", "name": "Des suppléments nutritionnels peuvent-ils aider ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certains suppléments, comme les acides gras oméga-3, peuvent soutenir la fonction cellulaire." } }, { "@type": "Question", "name": "Les médicaments anti-inflammatoires sont-ils utiles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent réduire l'inflammation et améliorer la fonction musculaire." } }, { "@type": "Question", "name": "La recherche sur les kinésines progresse-t-elle ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des études sont en cours pour développer de nouveaux traitements ciblés." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des troubles kinésines ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques, musculaires et métaboliques peuvent se développer." } }, { "@type": "Question", "name": "Les troubles kinésines peuvent-ils entraîner des maladies graves ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent contribuer à des maladies neurodégénératives comme la maladie d'Alzheimer." } }, { "@type": "Question", "name": "Y a-t-il des risques de paralysie avec des troubles kinésines ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles graves peuvent entraîner une paralysie ou une perte de mobilité." } }, { "@type": "Question", "name": "Les troubles kinésines peuvent-ils affecter la respiration ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications peuvent affecter les muscles respiratoires et la fonction pulmonaire." } }, { "@type": "Question", "name": "Des troubles kinésines peuvent-ils causer des problèmes cardiaques ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des dysfonctionnements peuvent affecter le cœur et la circulation sanguine." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles kinésines ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs génétiques, l'âge avancé et les maladies métaboliques augmentent le risque." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il les troubles kinésines ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent aggraver les troubles." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de troubles neurologiques augmentent le risque." } }, { "@type": "Question", "name": "Le stress est-il un facteur de risque pour les kinésines ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la fonction des kinésines et la santé cellulaire." } }, { "@type": "Question", "name": "L'exposition à des toxines influence-t-elle les kinésines ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certaines toxines peut nuire à la fonction des kinésines." } } ] } ] }

Sources (2047 au total)

Combination of transcriptome and Mendelian inheritance reveals novel prognostic biomarker of CTLA-4-related lncRNAs and protective role of nitrogen metabolism pathway in lung adenocarcinoma development.

Since in the cancer setting, tumor cells may use cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) to evade the immune system. This study aimed to identify CTLA-4-related long non-coding RNAs (lncR... Clinical and genomic data were obtained from The Cancer Genome Atlas (TCGA), MSigDB and Gene Weaver. CTLA-4-related lncRNA-based gene signatures (CTLA4LncSigs) were identified using Cox regression, es... Nineteen CTLA4LncSigs significantly influenced LUAD prognosis. The risk score demonstrated independence as a prognostic factor. Functional analysis revealed lncRNAs' impact on nitrogen metabolism. MR ... Our study identifies CTLA-4-related lncRNAs associated with LUAD prognosis and uncovers a previously undiscovered protective role of the nitrogen metabolism pathway in combating LUAD development, prov...

Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.

While the Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU) was ongoing, external data suggested higher doses were needed to achieve targeted effects; therefore, doses of gantenerumab were ... Using generalized linear mixed effects (LME) models, we estimated the annual low- and high-dose treatment effects in clinical, cognitive, and biomarker outcomes.... Both gantenerumab and solanezumab demonstrated dose-dependent treatment effects (significant for gantenerumab, non-significant for solanezumab) in their respective target amyloid biomarkers (Pittsburg... Mid-trial dose escalation can be implemented as a remedy for an insufficient initial dose and can be more cost effective and less burdensome to participants than starting a new trial with higher doses... We evaluated the dose-dependent treatment effect of two different amyloid-specific immunotherapies.Dose-dependent treatment effects were observed in some biomarkers.No dose-dependent treatment effects...

Exploring the mutational landscape of genes associated with inherited retinal disease using large genomic datasets: identifying loss of function intolerance and outlying propensities for missense changes.

Large databases permit quantitative description of genes in terms of intolerance to loss of function ('haploinsufficiency') and prevalence of missense variants. We explored these parameters in inherit... IRD genes (from the 'RetNet' resource) were classified by probability of loss of function intolerance (pLI) using online Genome Aggregation Database (gnomAD) and DatabasE of genomiC varIation and Phen... Of 280 analysed genes, 39 (13.9%) were predicted loss of function intolerant. A greater proportion of X-linked than autosomal IRD genes fulfilled these criteria, as expected. Most autosomal genes were... A minority of IRD-associated genes appear to be 'haploinsufficient'. Over-representation of spliceosome pathways was observed. When interpreting genetic tests, variants found in genes with over-repres...

Identification of numerous novel disease-causing variants in patients with inherited retinal diseases, combining careful clinical-functional phenotyping with systematic, broad NGS panel-based genotyping.

The widespread consensus is that genotyping is essential for patients with inherited retinal disease (IRD). Given the numerous ongoing gene therapy clinical trials for IRDs, identifying the pathogenic... We conducted a retrospective analysis of data between November 2016 and March 2018 from the Duke Center for Retinal Degenerations and Ophthalmic Genetic Diseases IRD patient database, which encompasse... By judiciously using this two-way approach and leveraging to its full potential the benefits of careful, in-depth clinical-functional phenotyping by an experienced IRD specialist, more than 80% of the... The combination of meticulous, expert clinical-functional phenotyping studies with systematic next-generation sequencing panel-based genotyping and microarray deletion/duplication testing or CNV analy...

Investigation of the current situation regarding diagnosis and treatment of Alport syndrome in Asian countries: results of survey of the Asian Paediatric Nephrology association (AsPNA) tubular and inherited working group.

Alport syndrome is one of the most common inherited kidney diseases worldwide. A genetic test or kidney biopsy is necessary for a definite diagnosis of this disease, and an accurate diagnosis system f... The group conducted an online survey among the members of AsPNA in 2021-2022. Collected data included the number of patients for each inheritance mode, availability of gene tests or kidney biopsy, and... A total of 165 pediatric nephrologists from 22 countries in Asia participated. Gene test was available in 129 institutes (78%), but the cost was still expensive in most countries. Kidney biopsy was av... This study result might suggest that the system is underdeveloped enough to diagnose all Alport syndrome patients in most Asian countries. However, once diagnosed with Alport syndrome, most of them we...

Current Management of Inherited Retinal Degeneration Patients in Europe: Results of a 2-Year Follow-Up Multinational Survey by the European Vision Institute Clinical Research Network - EVICR.net.

An increasing number of gene-specific therapies are being developed for inherited retinal degenerations (IRDs). Identification of well-characterized patients is an emerging need. We conducted the seco... An electronic survey questionnaire was developed and sent to 124 clinical centers (25 countries) by June/July 2021. Statistical analysis was performed with Excel and R.... The overall response rate was 44% but varied among countries. Only 9% of responding centers do not see IRD patients (2019 survey 14%), 42% follow at least 200 patients per year, 18% follow 500-999, an... This second multinational survey on management of IRDs in Europe highlights persistent important differences in the number of IRD patients managed per center, comparable diagnostic work-up, and increa...

Study of frequency and inheritance model of ACE1 I/D and ACE2 rs2285666 polymorphisms in COVID-19 patients with varying severity of lung involvement and its effect on serum cytokines levels.

The angiotensin-converting enzyme (ACE) has been shown to play a role as a receptor for the COVID-19 virus. This virus usually gets into cells and infects them by attaching to their glycoprotein recep...